What is an osteoblastoma (benign bone tumor)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Osteoblastoma is a rare, benign bone tumor that is classified as an intermediate tumor, locally aggressive or rarely metastasizing, according to the World Health Organization classification. This classification is based on the tumor's potential for local growth and rare metastatic spread [ 1 ]. Osteoblastoma is characterized by the formation of abnormal bone tissue and typically affects young adults, with a higher incidence in males than females. The tumor most frequently develops in the spine, particularly the vertebral arch, and long bones, though it can occur in any bone.

Key Characteristics of Osteoblastoma

  • Accounts for approximately 1% of all bone tumors
  • Typically affects young adults between the ages of 10 and 30
  • Males are more commonly affected than females
  • Most frequently develops in the spine and long bones
  • Patients typically present with localized pain that worsens at night and may be relieved by aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs)

Diagnosis and Treatment

The diagnosis of osteoblastoma relies on a coordinated evaluation of both clinical and radiologic information, including radiographs and advanced imaging modalities such as CT, MRI, or nuclear medicine [ 1 ]. Radiologically, osteoblastomas appear as well-circumscribed, lytic lesions with a sclerotic rim and may show internal calcification. Treatment usually involves complete surgical removal of the tumor through curettage or en bloc resection, depending on the size and location.

Prognosis

The prognosis is generally excellent with complete removal, though there is a small risk of recurrence if the tumor is not entirely excised [ 1 ]. Unlike some bone tumors, osteoblastomas rarely undergo malignant transformation. Overall, osteoblastoma is a rare but important bone tumor that requires prompt diagnosis and treatment to prevent complications and ensure a good prognosis.

From the Research

Definition and Characteristics of Osteoblastoma

  • Osteoblastoma is a rare, bone-forming neoplasm that accounts for 1% of primary bone tumors 2, 3.
  • It is characterized by interconnecting trabeculae of woven bone and rimmed by prominent osteoblasts 2.
  • Osteoblastoma frequently affects the long bones and the spine, with the most common sites of occurrence being the vertebral column and the humerus 2.

Demographic and Anatomic Prevalence

  • The average age of patients with osteoblastoma is around 24 years, with a range of 10 to 34 years 2, 4.
  • The cohort is predominantly male, with a male-to-female ratio of approximately 2:1 2.
  • The most common locations of osteoblastoma are the posterior elements of the spine, followed by the long bones of the extremities and the talus 4.

Treatment and Recurrence

  • The gold-standard treatment for osteoblastoma is surgical excision, which can be performed through en bloc resection or curettage with allograft or autograft 2, 3.
  • The recurrence rate following curettage is relatively high, ranging from 13% to 24%, and can be minimized by resective surgery in select cases 2, 4.
  • Minimally invasive techniques, such as radiofrequency thermoablation and high-intensity focused ultrasound, are gaining importance in the treatment of osteoblastoma, but surgery remains the preferred option for lesions close to nerves or joints, or in cases of unclear diagnosis or risk of fracture 3.

Surgical Management and Outcomes

  • Surgical management of osteoblastoma involves careful consideration of tumor characteristics, spinal instability, and neurological status 5.
  • Aggressive surgical resection is suggested to minimize the risk of tumor recurrence, although recurrence can still occur even with en bloc resection 5.
  • Patients with spinal osteoblastoma may require surgical fusion due to removal of structural elements of the spine during resection 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Osteoblastoma: a 30-year study of 99 cases.

Journal of surgical oncology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.